Inflammation comprises important aspects of large‐artery atherosclerosis (LAA) stroke pathophysiology. YKL‐40 is a new and emerging biomarker that is associated with both acute and chronic inflammations. Elevated serum concentrations of… Click to show full abstract
Inflammation comprises important aspects of large‐artery atherosclerosis (LAA) stroke pathophysiology. YKL‐40 is a new and emerging biomarker that is associated with both acute and chronic inflammations. Elevated serum concentrations of YKL‐40 have been reported in patients with atherosclerosis and other cardiovascular diseases. This study investigates whether serum YKL‐40 concentrations on admission can predict 3‐month clinical outcomes after LAA stroke.
               
Click one of the above tabs to view related content.